Additionally, a higher astrocytoma grade suggested stronger RBM3 expression, indicating that RBM3 overexpression might have proliferative and/or proto-oncogenic functions in humans [36]. This evidence concerns the gene RBM3 and astrocytoma (excluding glioblastoma).